Summit Therapeutics PLC
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q1 18 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q1 19 | Q2 19 | Q3 19 | Q1 20 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | 20.2 | 235.6 | 26.2 | 42.8 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 223.8 | 203.5 | 80.4 | 72.3 | 65.4 | 53.2 | 3.2 | 2.9 | 1.7 | 4.9 | – | 6.5 | 10.6 | 116.1 | 379.2 | 293.1 | 322.8 | 606.7 | 885.1 | 1,514.1 | 384.5 | 195.4 | 176.6 | 64.7 | 232.8 | 2,032.8 | 1,741.9 | 4,030.9 | 5,624.4 | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | 153.4 | 39.1 | 124.2 | 125.2 | 4.8 | 5.1 | 1.8 | 5.5 | – | 1.0 | 1.7 | – | 4.9 | 3.7 | 8.0 | 6.1 | 10.5 | 8.0 | 6.5 | 4.2 | 5.0 | 2.4 | 1.5 | 11.4 | 6.3 | 18.5 | 16.2 | 29.6 | 81.7 | 35.8 | 47.6 | 42.3 | 53.4 | 110.8 | 80.2 | 27.4 | 35.6 | 18.0 | |
| 209.0 | 199.0 | 76.9 | 69.2 | 62.9 | 51.4 | 2.9 | 2.7 | 1.2 | 4.3 | – | 2.6 | 7.5 | 53.4 | 325.7 | 251.2 | 300.0 | 523.5 | 824.6 | 1,351.6 | 338.9 | 174.9 | 152.8 | 34.4 | 736.1 | 1,745.9 | 1,854.5 | 4,190.5 | 6,324.1 | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | 55.7 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 35.3 | 59.9 | 24.2 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 2.8% | 1.7% | 4.1% | -2.3% | -2.2% | -2.1% | -22.8% | -21.0% | -35.6% | -8.5% | – | -33.1% | -26.9% | -25.7% | -15.5% | -21.9% | -21.2% | -13.9% | -10.0% | -6.9% | -10.6% | -20.4% | -21.6% | -55.3% | -25.5% | -2.9% | -4.4% | -2.1% | -3.2% | -3.4% | -2.6% | -1.4% | -0.6% | -0.9% | -1.0% | -1.1% | -1.6% | -2.1% | -2.2% | -3.8% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 99.7% | 99.7% | 865.7% | 954.2% | 1,101.9% | 7,342.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | -2.5% | -148.4% | -233.2% | -765.8% | – | – | – | – | – | – | – | – | – | – | – | |
| -1,045.9% | -602.2% | -243.1% | -184.8% | -160.4% | -147.7% | 13.8% | 3.5% | 32.9% | 38.4% | -214.5% | -170.1% | -430.8% | -3,300.2% | -5,254.2% | -6,287.7% | -8,279.7% | -10,221.2% | -10,230.1% | -12,777.9% | -4,066.5% | -4,721.7% | -4,878.9% | -3,961.1% | -8,058.3% | -10,197.5% | -122,272.4% | -110,884.1% | -204,253.6% | – | – | – | – | – | – | – | – | – | – | – | |
| -899.4% | -511.6% | -199.8% | -120.2% | -112.2% | -108.0% | 16.0% | 1.2% | 6.6% | 11.4% | -348.9% | -309.4% | -364.1% | -2,577.9% | -4,543.3% | -5,475.6% | -6,531.3% | -8,788.4% | -8,816.4% | -11,838.8% | -4,256.1% | -4,853.9% | -4,934.9% | -4,197.0% | -9,041.4% | -11,207.2% | -125,005.3% | -112,381.7% | -205,584.0% | – | – | – | – | – | – | – | – | – | – | – | |
| 634.1% | 339.6% | 332.3% | -165.6% | -144.9% | -112.1% | -73.8% | -61.8% | -61.5% | -41.6% | -111.3% | -215.2% | -285.6% | -2,987.7% | -5,881.5% | -6,410.5% | -6,835.0% | -8,431.6% | -8,836.3% | -10,480.4% | -4,063.5% | -3,985.5% | -3,822.4% | -3,580.6% | -5,931.0% | -5,902.4% | -7,730.5% | -8,611.6% | -17,749.9% | – | – | – | – | – | – | – | – | – | – | – | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| – | – | -381.5% | -65.0% | -213.2% | -254.4% | 23.6% | 2.2% | 6.7% | 12.9% | – | -48.0% | -57.2% | – | -58.9% | -68.8% | -162.0% | -87.8% | -104.4% | -62.4% | -72.4% | -105.2% | -139.6% | -152.9% | -57.5% | -63.1% | -452.5% | -515.0% | -593.2% | -808.9% | -261.7% | -83.3% | -45.8% | -55.7% | -70.3% | -259.9% | -291.9% | -149.6% | -210.7% | -135.9% | |
| -45.5% | -51.8% | -32.4% | -21.5% | -19.3% | -23.0% | 16.7% | 1.3% | 4.8% | 9.3% | – | -33.4% | -39.0% | -26.7% | -43.1% | -66.2% | -105.0% | -68.0% | -47.8% | -51.3% | -57.5% | -77.2% | -77.2% | -82.0% | -49.3% | -12.0% | -236.9% | -259.5% | -269.8% | -309.7% | -65.4% | -47.5% | -39.9% | -49.8% | -63.0% | -190.9% | -214.4% | -131.2% | -177.5% | -113.8% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| -35 | -18 | -30 | -35 | -38 | -34 | -19 | -16 | -32 | -30 | – | -25 | -17 | -47 | -36 | -29 | -16 | -48 | -33 | -74 | -59 | -27 | -33 | -47 | 386 | -167 | 44 | 69 | 165 | 46 | 54 | 59 | -50 | -81 | -161 | -175 | – | -165 | -78 | -416 | |
| – | – | – | – | – | – | -5.7 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -9.3% | -25.8% | 8.5% | 33.1% | 9.1% | 9.1% | 70.7% | 62.5% | 71.2% | 72.0% | – | 69.6% | 68.3% | -163.7% | 73.2% | 96.3% | 64.8% | 77.5% | 45.7% | 82.1% | 79.5% | 73.5% | 55.3% | 53.6% | 85.8% | 19.1% | 52.4% | 50.4% | 45.5% | 38.3% | 25.0% | 57.1% | 87.1% | 89.3% | 89.7% | 73.5% | 73.5% | 87.7% | 84.3% | 83.8% | |
| – | – | 1.5 | 0.3 | 0.0 | 0.6 | 0.1 | 0.0 | 0.1 | 0.1 | – | 0.0 | 0.0 | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.9 | 0.0 | 0.0 | 0.4 | 0.5 | 0.0 | 4.1 | 1.1 | 0.9 | 1.1 | 2.3 | 1.7 | 2.9 | 0.5 | 0.1 | 0.0 | 0.0 | 0.0 | – | 0.0 | 0.0 | 0.0 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -0.35 | -0.33 | -0.28 | -0.21 | -0.22 | -0.26 | 0.12 | 0.01 | 0.05 | 0.04 | – | -0.62 | -0.62 | -0.53 | -0.46 | -0.56 | -0.69 | -0.68 | -0.59 | -0.59 | -0.55 | -0.67 | -0.70 | -0.65 | -0.47 | -0.24 | -1.29 | -0.70 | -0.69 | -0.71 | -0.13 | -0.18 | -0.21 | -0.23 | -0.25 | -0.50 | -0.75 | -0.95 | -1.12 | -1.10 | |
| 0.04 | 0.07 | 0.14 | 0.17 | 0.20 | 0.24 | 0.77 | 0.75 | 0.69 | 0.37 | – | 0.20 | 0.17 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| -0.07 | -0.17 | 0.07 | 0.32 | 0.10 | 0.10 | 0.53 | 0.43 | 0.68 | 0.33 | – | 1.29 | 1.08 | -3.27 | 0.77 | 0.82 | 0.42 | 0.78 | 0.56 | 0.94 | 0.77 | 0.64 | 0.50 | 0.42 | 0.81 | 0.38 | 0.29 | 0.14 | 0.12 | 0.09 | 0.05 | 0.22 | 0.46 | 0.42 | 0.36 | 0.19 | 0.26 | 0.64 | 0.53 | 0.81 | |
| 0.24 | 0.22 | 0.47 | -0.29 | -0.29 | -0.27 | -0.57 | -0.46 | -0.43 | -0.15 | – | -0.43 | -0.48 | -0.62 | -0.59 | -0.66 | -0.72 | -0.65 | -0.59 | -0.52 | -0.53 | -0.55 | -0.54 | -0.55 | -0.31 | -0.12 | -0.08 | -0.05 | -0.06 | -0.09 | -0.11 | -0.11 | -0.12 | -0.15 | -0.18 | -0.24 | -0.33 | -0.37 | -0.43 | -0.55 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.